Remove Molecular Biology Remove RNA Remove Vaccine Remove Workshop
article thumbnail

Turning science into business: Merging AI and RNA

Drug Discovery World

DDW’s Diana Spencer speaks to Raphael Townshend PhD, Founder and CEO of Atomic AI, about the company’s successes so far, plans for the future and the unique approach of combining RNA structural biology and AI models. DS: How is Atomic AI “unlocking the next generation of RNA drug discovery”? What is unique about your engine?

RNA 130
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . It’s now possible to programme cell-free systems to make RNA and proteins that interact with each other,” Dr Laohakunakorn continues.

DNA 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Protein Printer

Codon

We are living through an inflection point in biology’s history, in which a simple laptop can design proteins with wondrous new functions. Scientists at the Institute for Protein Design have crafted proteins that self-assemble into nanomaterials or that can be used as vaccines for the flu and HIV. This is simple.

RNA 64
article thumbnail

A Protein Printer

Codon

We are living through an inflection point in biology’s history, in which a simple laptop can design proteins with wondrous new functions. Scientists at the Institute for Protein Design have crafted proteins that self-assemble into nanomaterials or that can be used as vaccines for the flu and HIV. This is simple.

RNA 52